FDA 'rapidly works toward' approval of Johnson and Johnson vaccine
The US Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson and Johnson's (JNJ) single-shot Covid-19 vaccine candidate.